{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T11:50:16Z","timestamp":1778932216288,"version":"3.51.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,7,1]],"date-time":"2010-07-01T00:00:00Z","timestamp":1277942400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Langenbecks Arch Surg"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00423-010-0665-7","type":"journal-article","created":{"date-parts":[[2010,6,29]],"date-time":"2010-06-29T23:58:51Z","timestamp":1277855931000},"page":"127-132","source":"Crossref","is-referenced-by-count":8,"title":["Reduction of adhesion formation by an angiotensin type 1 receptor antagonist"],"prefix":"10.1007","volume":"396","author":[{"given":"Yasuyuki","family":"Tokinaga","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Kimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koji","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Mizumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuaki","family":"Tange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshio","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,1]]},"reference":[{"key":"665_CR1","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1046\/j.1365-2168.2001.01647.x","volume":"88","author":"K Falk","year":"2001","unstructured":"Falk K, Bj\u00f6rquist P, Str\u00f6mqvist M, Holmdahl L (2001) Reduction of experimental adhesion formation by inhibition of plasminogen activator type 1. Br J Surg 88:286\u2013289. doi: 10.1046\/j.1365-2168.2001.01647.x","journal-title":"Br J Surg"},{"key":"665_CR2","first-page":"60","volume":"72","author":"D Menzies","year":"1990","unstructured":"Menzies D, Ellis H (1990) Intestinal obstruction from adhesions\u2014how big is the problem? Ann R Coll Surg Engl 72:60\u201363","journal-title":"Ann R Coll Surg Engl"},{"key":"665_CR3","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/S0140-6736(99)90061-2","volume":"353","author":"L Holmdahl","year":"1999","unstructured":"Holmdahl L (1999) Making and covering of surgical footprints. Lancet 353:1456\u20131457","journal-title":"Lancet"},{"key":"665_CR4","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/nm1733","volume":"14","author":"H Kosaka","year":"2008","unstructured":"Kosaka H, Yoshimoto T, Yoshimoto T, Fujimoto J, Nakanishi K (2008) Interferon-gamma is a therapeutic target molecule for prevention of postoperative adhesion formation. Nat Med 14:437\u2013441. doi: 10.1038\/nm1733","journal-title":"Nat Med"},{"key":"665_CR5","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0895-7061(01)02273-7","volume":"15","author":"DE Vaughan","year":"2002","unstructured":"Vaughan DE (2002) Angiotensin and vascular fibrinolytic balance. Am J Hypertens 15:3S\u20138S","journal-title":"Am J Hypertens"},{"key":"665_CR6","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1161\/01.ATV.20.10.2297","volume":"20","author":"HC Chen","year":"2000","unstructured":"Chen HC, Bouchi JL, Perez AS, Clermont AC, Izumo S, Hampe J et al (2000) Role of the angiotensin AT1 receptor in rat aortic and cardiac PAI-1 gene expression. Arterioscler Thromb Vasc Biol 20:2297\u20132302","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"665_CR7","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1161\/01.HYP.37.3.961","volume":"37","author":"L Sironi","year":"2001","unstructured":"Sironi L, Calvio AM, Arnaboldi L, Corsini A, Parolari A, Gasparo M et al (2001) Effect of valsartan on angiotensin II-induced plasminogen activator inhibitor-1 biosynthesis in arterial smooth muscle cells. Hypertension 37:961\u2013966","journal-title":"Hypertension"},{"key":"665_CR8","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.atherosclerosis.2004.07.008","volume":"177","author":"KK Koh","year":"2004","unstructured":"Koh KK, Chung WJ, Ahn JY, Han SH, Kang WC, Seo YH et al (2004) Angiotensin II type 1 receptor blockers reduce tissue factor activity and plasminogen activator inhibitor type-1 antigen in hypertensive patient: a randomized, double-blind, placebo-controlled study. Atherosclerosis 177:155\u2013160. doi: 10.1016\/j.atherosclerosis.2004.07.008","journal-title":"Atherosclerosis"},{"key":"665_CR9","first-page":"117","volume":"65","author":"GB Ryan","year":"1971","unstructured":"Ryan GB, Grob\u00e8ty J, Majno G (1971) Postoperative peritoneal adhesions. Am J Path 65:117\u2013148","journal-title":"Am J Path"},{"key":"665_CR10","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0002-9610(02)00876-0","volume":"184","author":"YD Zhang","year":"2002","unstructured":"Zhang YD, Yao W, Wu CX, Chi QM, Zhang JY, Li M (2002) Topical application of halcinonide cream reduces the severity and incidence of intraperitoneal adhesions in a rat model. Am J Surg 184:74\u201377","journal-title":"Am J Surg"},{"key":"665_CR11","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1213\/00000539-199301000-00007","volume":"76","author":"M Hirose","year":"1993","unstructured":"Hirose M, Hashimoto S, Tanaka Y (1993) Effect of the head-down tilt position during lower abdominal surgery on endocrine and renal function response. Anesth Analg 76:40\u201344","journal-title":"Anesth Analg"},{"key":"665_CR12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ejphar.2003.11.009","volume":"484","author":"Y Okamoto","year":"2004","unstructured":"Okamoto Y, Takai S, Miyazaki M (2004) Significance of chymase inhibition for prevention of adhesion formation. Eur J Pharmacol 484:357\u2013359. doi: 10.1016\/j.ejphar.2003.11.009","journal-title":"Eur J Pharmacol"},{"key":"665_CR13","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2004.08.040","volume":"501","author":"S Takai","year":"2004","unstructured":"Takai S, Jin D, Muramatsu M, Okamoto Y, Miyazaki M (2004) Therapeutic application of chymase inhibitors in cardiovascular diseases and fibrosis. Eur J Pharmacol 501:1\u20138. doi: 10.1016\/j.ejphar2004.08.040","journal-title":"Eur J Pharmacol"},{"key":"665_CR14","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1161\/01.HYP.35.1.150","volume":"35","author":"NK Hollenberg","year":"2000","unstructured":"Hollenberg NK (2000) Implications of species difference for clinical investigation: studies on the renin-angiotensin System. Hypertension 35:150\u2013154","journal-title":"Hypertension"},{"key":"665_CR15","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0022-3565(25)38647-7","volume":"268","author":"Y Inada","year":"1994","unstructured":"Inada Y, Wada T, Shibouta Y, Ojima M, Sanada T, Ohtsuki K et al (1994) Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+\u2212)-1-(cyclohexyloxycarbonyloxy) ethyl-2-ethoxy-1-[[2\u2032-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. J Pharmacol Exp Ther 268:1540\u20131547","journal-title":"J Pharmacol Exp Ther"},{"key":"665_CR16","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/S0002-9378(94)70030-3","volume":"171","author":"N Chegini","year":"1994","unstructured":"Chegini N, Simms J, Williams RS, Masterson BJ (1994) Identification of epidermal growth factor, transforming growth factor-alpha, and epidermal growth factor receptor in surgically induced pelvic adhesions in the rat and intraperitoneal adhesions in the human. Am J Obstet Gynecol 171:321\u2013327","journal-title":"Am J Obstet Gynecol"},{"key":"665_CR17","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/0006-2952(96)00171-2","volume":"52","author":"A Sachinidis","year":"1996","unstructured":"Sachinidis A, El-Haschimi K, Ko Y, Seul C, Dusing R, Vetter H (1996) CV-11974, the active metabolite of TCV-116 (candesartan), inhibits the synergistic or additive effect of different growth factors on angiotensin II-induced proliferation of vascular smooth muscle cells. Biochem Pharmacol 52:123\u2013126","journal-title":"Biochem Pharmacol"},{"key":"665_CR18","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1161\/01.CIR.0000140265.21608.8E","volume":"110","author":"D Fliser","year":"2004","unstructured":"Fliser D, Buchholz K, Haller H, European trial on olmesartan and pravastatin in inflammation and atherosclerosis (EUTOPIA) investigators (2004) Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 110:1103\u20131107. doi: 10.1161\/01.CIR.0000140265.21608.8E","journal-title":"Circulation"},{"key":"665_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1081\/CEH-120027328","volume":"26","author":"K Lottermoser","year":"2004","unstructured":"Lottermoser K, Hertfelder HJ, Gohlke P, Vetter H, D\u00fcsing R (2004) Short-term effects of exogenous angiotensin II on plasma fibrinolytic balance in normal subjects. Clin Exp Hypertens 26:13\u201326. doi: 10.1081\/CEH-120027328","journal-title":"Clin Exp Hypertens"},{"key":"665_CR20","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1463-1326.2004.00316.x","volume":"6","author":"T Skurk","year":"2004","unstructured":"Skurk T, Lee YM, Nicuta-Rolfs TO, Haastert B, Wirth A, Hauner H (2004) Effect of the angiotensin II receptor blocker candesartan on fibrinolysis in patients with mild hypertension. Diab Obes Metab 6:56\u201362","journal-title":"Diab Obes Metab"},{"key":"665_CR21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1002\/bjs.1800820346","volume":"82","author":"D Scott-Coombes","year":"1995","unstructured":"Scott-Coombes D, Whawell S, Vipond MN, Thompson J (1995) Human intraperitoneal fibrinolytic response to elective surgery. Br J Surg 82:414\u2013417","journal-title":"Br J Surg"},{"issue":"Suppl","key":"665_CR22","first-page":"139(S-915)","volume":"24","author":"T Kondo","year":"1996","unstructured":"Kondo T, Hagihara K, Kato Y, Yoshida K, Yoshimura Y, Motohashi M et al (1996) Metabolic fate of TCV-116, a new angiotensin II receptor antagonist, in rats and dogs. Jpn Pharmacol Ther 24(Suppl):139(S-915)\u2013167(S-943)","journal-title":"Jpn Pharmacol Ther"}],"container-title":["Langenbeck's Archives of Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-010-0665-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00423-010-0665-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00423-010-0665-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,22]],"date-time":"2025-02-22T10:06:55Z","timestamp":1740218815000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00423-010-0665-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,1]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["665"],"URL":"https:\/\/doi.org\/10.1007\/s00423-010-0665-7","relation":{},"ISSN":["1435-2443","1435-2451"],"issn-type":[{"value":"1435-2443","type":"print"},{"value":"1435-2451","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,1]]}}}